Tafenoquine Uses, Dosage, Side Effects and Interactions
Arakoda
Arakoda was approved by the FDA in August 2018 as a tablet.
Krintafel
Krintafel was the first tafenoquine product the FDA approved, in July 2018.
Kodatef
Kodatef is a brand of tafenoquine that comes as a tablet.
Tafenoquine is an antimalarial medicine used to prevent malaria (Arakoda, Kodatef) and to prevent relapse of Plasmodium vivax malaria after chloroquine treatment (Krintafel).
Quick links
Ask Anything About TafenoquineType a question in your own words. Answered from its FDA label in seconds.Every other section of this page is in the dots on the left edge of your screen: point at one to see where it goes.Every other section of this page is one tap away: use the arrow tab on the left edge of your screen.
Tafenoquine in Short
What it treatsTafenoquine is used in two ways, depending on the product. Arakoda is used to prevent malaria (prophylaxis) in adults 18 and older. Kodatef is used for malaria prophylaxis, consistent with Arakoda's approved use.
- How you get it Prescription only
- Comes asTablet (by mouth)
- Crushing or chewingSome forms are on our Do Not Crush list Listed: Arakoda (tablet); Krintafel (tablet); and 1 more
- Important safety informationWarnings and precautions Read the warnings and precautions for your exact product.
- Supplements and herbs17 interact 1 major, 7 moderate and 9 minor
- Generic launchDecember 2035 Our estimate for the first generic of Arakoda
The Pharmacist’s Take
Tafenoquine, a newer antimalarial related to primaquine and on the U.S. market since about 2018, prevents malaria in travelers (Arakoda, Kodatef) and, as Krintafel, stops P. vivax malaria from relapsing by clearing dormant parasites from the liver. Most people tolerate it reasonably well, with headache, nausea, diarrhea, poor sleep and vivid dreams the usual complaints. Its main danger is red blood cell breakdown (hemolytic anemia) in people with G6PD deficiency, an inherited enzyme shortage, so a blood test comes first, and dark urine or yellow skin means stop and get care. Avoid it with any history of psychotic illness, and since it lingers for weeks, problems can start late.
Key Takeaways From the HelloPharmacist Team
- For travel, take it with food daily for the three days before you go, weekly while there, and once the week after.
- Get care right away for hives or swelling, and report hallucinations, severe mood changes, or anxiety or nightmares lasting over three days.
- Women who could become pregnant need a pregnancy test first and should use effective birth control until three months after the last dose.
- Krintafel is one dose taken with chloroquine, so avoid other antimalarials and flag metformin or dofetilide, whose levels it can raise.
Patient Information Guide for Tafenoquine
What It’s Used For
Tafenoquine is an antimalarial with different approved uses depending on the product.
- Arakoda (oral tablet): prevents malaria in adults 18 and older.
- Kodatef (oral tablet): malaria prophylaxis, consistent with Arakoda's approved use.
- Krintafel (oral tablet): radical cure (prevention of relapse) of Plasmodium vivax malaria in people 16 and older receiving chloroquine for acute infection.
- Krintafel is not for treating acute P. vivax malaria.
How It Works
Tafenoquine is an 8-aminoquinoline antimalarial. It is active against all stages of the malaria parasite, including the dormant liver stage called the hypnozoite, which is what causes relapse.
In lab studies it may interfere with hematin polymerization and trigger parasite cell death. It also shrinks red blood cells in the lab. Its exact molecular target is unknown.
Drug Class
WHO drug family
- Aminoquinolines
Detailed classifications and sources
The FDA sorts a drug’s active ingredient by how it works, what it does in the body and its chemical structure, and gives it one main drug class.
Drug Class
Established Pharmacologic Class (EPC)None. The FDA’s index lists no class of any kind for Tafenoquine.
The main drug class the FDA gives it. It is the class named on the drug’s label.
What It Does in the Body
Physiologic effect (PE)None listed for Tafenoquine in the FDA’s index.
From our Patient Information GuideTafenoquine is an 8-aminoquinoline antimalarial. It is active against all stages of the malaria parasite, including the dormant liver stage called the hypnozoite, which is what causes relapse. Read How Tafenoquine Works
A change it makes in how the body works.
Drug Family
WHO ATC classification- Aminoquinolines
How the World Health Organization groups it: by the part of the body it acts on and what it treats.
The description under What It Does in the Body is written by the HelloPharmacist team, not the FDA. Read the FDA’s definitions. The drug family is the World Health Organization’s ATC classification, from the U.S. National Library of Medicine’s RxClass. Reference only, not medical advice.
Dosage
Tafenoquine tablets are taken by mouth with food and swallowed whole.
- Arakoda: a daily loading phase for 3 days before travel, a weekly dose while in the malaria area, and one final dose the week after leaving. It can be used for up to 6 months of continuous dosing. Finish the full course. Missed-dose rules depend on which dose you missed, so check the label or ask your pharmacist.
- Krintafel: a single dose taken on the first or second day of chloroquine. If you vomit within 1 hour, one repeat dose should be given.
- Kodatef: daily loading for three days, then once weekly starting seven days after the last loading dose.
Follow your prescriber and the label.
Typical Doses
Your prescriber chooses your dose, so take it exactly as prescribed.
Arakoda
Preventing malaria
Adults 18 years and older · Loading regimen, before travel Usual dose 200 mg once a day
- 200 mg (2 of the 100 mg tablets) once daily for 3 days, for each of the 3 days before travel to a malarious area
Good to know
Administer with food
Adults 18 years and older · Maintenance regimen, while in the malarious area Usual dose 200 mg once a week
- 200 mg (2 of the 100 mg tablets) once weekly – start 7 days after the last loading regimen dose, while in the malarious area
Good to know
Administer with food; can be given for up to 6 months of continuous dosing
Adults 18 years and older · Terminal prophylaxis regimen, after leaving the area Usual dose 200 mg one time
- 200 mg (2 of the 100 mg tablets) taken one time, 7 days after the last maintenance dose, in the week following exit from the malarious area
Good to know
Administer with food
Krintafel
Preventing relapse of P. vivax malaria
For people 16 years and older taking chloroquine
Usual dose 300 mg one time
- Single dose of 300 mg administered as two 150-mg tablets taken together, on the first or second day of chloroquine therapy
Good to know
Give with food; repeat dose once if vomiting within 1 hour after dosing
Kodatef
Preventing malaria
Malaria prophylaxis, loading dose (kodatef) Usual dose 200 mg once a day
- 200 mg (two of the 100 mg filmcoated tablets) once daily for three days
What a loading dose is: A larger dose given at the start to quickly build the medicine up to an effective level in the body.
Malaria prophylaxis, maintenance dose (kodatef) Usual dose 200 mg once a week
- 200 mg (two of the 100 mg filmcoated tablets) once weekly – start seven days after the last loading dose
What a maintenance dose is: The regular ongoing dose taken to keep a steady, effective amount of medicine in the body over time.
Side Effects
Most side effects in trials were mild and often similar to placebo.
Common side effects
- Headache
- Dizziness
- Back pain
- Diarrhea
- Nausea
- Vomiting
- Trouble sleeping or abnormal dreams
- Raised liver enzyme (ALT) on blood tests
- Anxiety or depressed mood
When to get medical help
- Dark urine, unusual tiredness, paleness or yellow skin or eyes could signal hemolytic anemia (red blood cells breaking down). Stop the medicine and get medical care.
- Signs of methemoglobinemia (a blood problem that lowers oxygen delivery) need prompt medical attention.
- Hallucinations, delusions or very disorganized thinking or behavior need prompt evaluation by a mental health professional.
- Mood changes, anxiety, insomnia or nightmares that are moderate and last more than 3 days, or are severe, should be evaluated promptly.
- Swelling (angioedema), hives or other allergic reactions need medical care right away.
- Because tafenoquine stays in the body a long time, problems can start late or last longer than expected.
Seek care for signs of red blood cell breakdown, methemoglobinemia, hallucinations or severe mood changes, or allergic reactions like hives or swelling.
Warnings and Precautions
- Hemolytic anemia: G6PD testing is required first. Stop and seek care if signs appear.
- Methemoglobinemia: blood levels rose without symptoms in some people. Seek care if symptoms appear.
- Psychiatric effects: sleep problems, depressed mood and anxiety occurred. Psychosis was reported in people with a history of psychosis at doses different from the approved dose.
- Allergic reactions: serious ones, such as angioedema and hives, have occurred.
- Delayed effects: the long half-life means problems may start late or last longer.
- Eyes: vortex keratopathy was common and resolved within a year after stopping.
Interactions
The main concern is with drugs moved through certain transporters.
- OCT2 and MATE substrates such as metformin and dofetilide: tafenoquine may raise their levels and increase toxicity risk. Avoid combining when possible (labeled for Krintafel).
- Other antimalarials besides chloroquine with Krintafel: not recommended because malaria may recur.
- In studies, tafenoquine did not significantly affect drugs handled by CYP1A2, CYP2D6, CYP2C9 or CYP3A4.
Interactions Listed in the FDA-Approved Label
From the Tafenoquine prescribing information (“Drug Interactions”): what the manufacturer studied or reported to the FDA.
-
OCT2 and MATE substrates For example: dofetilide, metforminWhat happensIn vitro observations suggest tafenoquine may increase concentrations of these drugs, which may increase the risk of their toxicity; the effect in humans is unknown.What to doAvoid coadministration. If it cannot be avoided, monitor for drug-related toxicities and consider dosage reduction if needed based on the approved labeling of the coadministered drug.
Read the label’s full interactions text
7 DRUG INTERACTIONS Avoid coadministration with drugs that are substrates of organic cation transporter-2 (OCT2) or multidrug and toxin extrusion (MATE) transporters. 7.1 Effect of KRINTAFEL on Organic Cation Transporter-2 (OCT2) and Multidrug and Toxin Extrusion (MATE) Substrates The effect of coadministration of tafenoquine on the pharmacokinetics of OCT2 and MATE substrates in humans is unknown. However, in vitro observations suggest the potential for increased concentrations of these substrates which may increase the risk of toxicity of these drugs. Avoid coadministration of KRINTAFEL with OCT2 and MATE substrates (e.g., dofetilide, metformin). If coadministration cannot be avoided, monitor for drug-related toxicities and consider dosage reduction if needed based on approved product labeling of the coadministered drug.
Not a complete list. The label covers the interactions the manufacturer studied or reported, and our own interaction database does not cover every medicine either. Bring your full medication list, including vitamins and herbal products, to your pharmacist.
Before You Start
- G6PD deficiency or unknown G6PD status: must not take it.
- History of psychotic disorders or current psychotic symptoms: must not take it.
- Allergy to tafenoquine or other 8-aminoquinolines: must not take it.
- Pregnancy: not recommended. A pregnancy test is advised first, and avoid pregnancy or use effective contraception for 3 months after the last dose (Arakoda) or after the dose (Krintafel).
- Breastfeeding: avoid if the infant is G6PD deficient or unknown, for 3 months after the last dose.
- Age: Krintafel is for 16 and older; Arakoda for 18 and older.
- Kidney or liver impairment: not studied, so monitoring is needed.
- Older adults: Krintafel trials did not include enough people 65 and older to tell if they respond differently.
Overdose
No overdose cases were reported with Arakoda. An overdose could cause a drop in hemoglobin and methemoglobinemia. Treatment is symptomatic and supportive care.
Half-Life and How Your Body Processes It
Tafenoquine is mostly bound to proteins in the blood and is barely metabolized. Its half-life is long, about 16.5 days on average. Peak levels occur about 14 hours after a dose with food, and levels build up with weekly dosing. Age, sex, ethnicity and body weight did not significantly change how it is handled. Its full excretion profile is unknown.
Storage
Store at less than 30°C (86°F). Protect from moisture.
Written from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Supplements and Herbs That Interact With Tafenoquine
From the licensed clinical database we use, rolled up per supplement, most serious first.17 supplements and herbal products have documented interactions with Tafenoquine in the licensed clinical database we use.
Most are manageable, but your pharmacist should know about everything you take, including vitamins and herbals.
- 1Major
- 7Moderate
- 9Minor
- ACTIVATED CHARCOALMajor
- COFFEE CHARCOALModerate
- EUROPEAN MANDRAKEModerate
- GLUCOMANNANModerate
- GUAR GUMModerate
- GUM ARABICModerate
- SLIPPERY ELMModerate
- TRAGACANTHModerate
Educational information from a licensed clinical database (Natural Medicines). See our data sources and update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.
Tafenoquine: Pharmacist Answers to Common Questions
Quick, plain-English answers to the questions patients ask most about Tafenoquine — the kind of thing our pharmacy team would talk through with you at the counter.
What is tafenoquine for?
Why do I need a blood test before starting?
How should I take it?
What side effects should I expect?
Can I take it if I'm pregnant or breastfeeding?
Does it interact with other medicines?
Is tafenoquine available over the counter?
When was tafenoquine first available?
Who makes tafenoquine?
What is the brand name of tafenoquine?
What is the generic name of Arakoda?
What strengths does tafenoquine come in?
Is there a tafenoquine shortage?
Where can I read the tafenoquine prescribing information (package insert)?
Can you crush tafenoquine?
Is tafenoquine gluten free?
Answers drafted from the FDA-approved label with AI and reviewed by our pharmacy team. How we use AI
Ask Anything About Tafenoquine
Skip the scrolling. Ask in your own words and get an answer from Tafenoquine’s FDA label and our pharmacists’ own work.
Name another drug or a supplement in your question and we check both.
AI answers from FDA labels and our own records, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.How this works
- Sources: Tafenoquine’s FDA label, including the clinical studies it reports, and the label of any drug you name; our pharmacists’ own work, such as our Do Not Crush list and our published answers to readers’ questions; our pharmacy prices and the Natural Medicines supplement database.
- Written by AI: Answers are written by AI from those sources, and AI can make mistakes. Check what you read here with your doctor or pharmacist before you act on it.
- Reviewed afterward: Our pharmacy team reviews every question and answer afterward to check it for accuracy, and when we find an error, we correct how the box answers. Read more in How we use AI.
- Not medical advice. In an emergency, call 911, Poison Control at 1-800-222-1222, or 988.
More About Tafenoquine on HelloPharmacist
Still have a question? A licensed pharmacist answers for free, as soon as they can.Tafenoquine Forms and Strengths (How It Comes)
Tafenoquine comes in 1 dose form, the tablet. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Need a version that does not list lactose, a gluten source, a dye or gelatin? Inactive ingredients differ by manufacturer: see Tafenoquine inactive ingredients by manufacturer.
Tablet
How this form is used
- Arakoda tablets are used to prevent malaria in adults 18 and older.
- Kodatef tablets are used for malaria prophylaxis, consistent with Arakoda's approved use.
- Krintafel tablets are used to prevent relapse of P. vivax malaria in people 16 and older taking chloroquine.
- Arakoda is taken with food in a loading, weekly maintenance and final dose schedule; swallow whole.
- Krintafel is taken once with food, on the first or second day of chloroquine; repeat once if vomiting occurs within 1 hour.
- Kodatef uses a daily loading phase for three days, then a once-weekly maintenance dose.
- Swallow Arakoda and Krintafel tablets whole; do not break, crush or chew them.
Tafenoquine on the U.S. Market: Products, Makers and Brands
How Tafenoquine appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
2 companies list 3 Tafenoquine product records with the FDA, mostly as tablet; the earliest marketing or approval year on record is 2018. Brand names in the directory today include Arakoda, Krintafel and Kodatef; the rest are generics.
Also listed with the FDA, not a patient dose form: Powder (2) — bulk drug substance and unfinished product sold to compounders and other manufacturers to finish, and multi-item kits. These aren’t counted in the dose-form total above.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Compare Tafenoquine Products
A representative set of FDA-listed product records for Tafenoquine — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Tablet | ||||
| 100 mg | Oral | 60 Degrees Pharmaceuticals, INC | UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE | View NDC → |
| 100 mg | Oral | 60 Degrees Pharmaceuticals, INC. | NDA | View NDC → |
| 150 mg | Oral | GlaxoSmithKline LLC | NDA | View NDC → |
Showing 3 of 3 products — FDA National Drug Code Directory. See every product, package size and price: browse all 3 Tafenoquine NDCs →
Tafenoquine Side Effects Reported to the FDA (FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Tafenoquine — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Tafenoquine in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
Tafenoquine FDA Approval History
How Tafenoquine went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
Tafenoquine Recall History
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
The FDA’s enforcement reports list no Tafenoquine recalls since July 2021.
✅No Tafenoquine recalls on record since July 2021Source: FDA enforcement (recall) reports, via openFDA; our copy was last updated Nov 19, 2026.
Tafenoquine in RxNorm: From Ingredient to Every Form and Strength
RxNorm is the U.S. National Library of Medicine’s standard name for every version of a medicine, the code pharmacy and prescribing systems share. This page starts from one ingredient (IN); each dose form (SCDF) branches from it, and each exact strength (SCD) from its form. Combination products are separate concepts with their own pages.
- Dose forms
- 1
- Strengths
- 2
- Forms in current FDA listings
- 1 of 1
RxCUI 2054023 RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
Tafenoquine Supply and Shortage Status
Whether Tafenoquine is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
Tafenoquine Brand Names
Tafenoquine has 3 brand names on record: Arakoda, Krintafel and Kodatef. A brand name is one company's name for the medicine; a generic has the same active ingredient under its generic name.
Who Makes Tafenoquine: Manufacturers and Labelers
2 companies list Tafenoquine products with the FDA. By number of product records, the largest are 60 Degrees Pharmaceuticals, INC, GlaxoSmithKline LLC. Labelers include manufacturers and repackagers; the product in your bottle depends on which one your pharmacy stocks.
Sources for This Tafenoquine Page
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How this page is built
HelloPharmacist combines public FDA and NLM records and does not author the underlying clinical facts. The plain-language sections are written with AI from the FDA-approved label text and reviewed by our pharmacy team before publication. 60 Degrees Pharmaceuticals, INC. is the representative DailyMed label linked for verification and dates. This is general education, not medical advice: always talk to your doctor or pharmacist about your own medicines. How we build and review drug pages →